The National Pharmaceutical Pricing Authority (NPPA) on March 25, 2026, issued amendment in the Manufacturer Details in Retail Price Notification (2018).
The National Pharmaceutical Pricing Authority (NPPA) has issued a correction to its earlier notification dated November 02, 2018, regarding the fixation of retail price. For Sl. No. 7 in the table, the name of the manufacturer/marketing company has been revised to “M/s Sun Pharmaceutical Industries Limited,” replacing the earlier mention of both “M/s Pure and Cure Healthcare Pvt. Ltd.” and “M/s Sun Pharmaceutical Industries Limited.”
All other details, notes, and provisions of the original notification remain unchanged.
[Notification No. S.O. 1592(E)]
